• Levent Aydin, Duygu Dereli, Tufan Agah Kartum, Deniz Sirinoglu, Balkan Sahin, Murat Sakir Eksi, Ahmet Murat Musluman, and Adem Yilmaz.
• Department of Neurosurgery, Medicana International Istanbul, Istanbul, Turkey. Electronic address: mdleventaydin@gmail.com.
• World Neurosurg. 2024 Feb 1; 182: e360e368e360-e368.

BackgroundThe treatment of persistent syringomyelia associated with Chiari malformation type 1 (CM1) is unclear. This study aims to evaluate the clinical and radiologic outcomes of syringo-subarachnoid shunt (SSS) as a treatment for persistent syringomyelia following posterior fossa decompression (PFD) for CM1.MethodsForty-nine cases treated for CM1 associated syringomyelia at a single center were analyzed, 17 of them undergoing reoperation due to persistent syrinx formation. The patients' demographic data, neurologic presentations, and radiologic results were analyzed, including cerebellar herniation, posterior fossa volume, the level at which the syrinx started and finished, the size and diameter of the syrinx.ResultsSeventeen patients underwent SSS placement, with 1 minor surgical complication (a cerebrospinal fluid leak) occurring and requiring revision. No morbidity or mortality was observed. Among these 17 reoperated patients, partial or complete resorption of the syrinx was observed in all cases. The results suggest that if the syrinx diameter is >10 mm at its thickest point, extends for more than 10 vertebrae, and starts from the upper cervical region and extends to the upper thoracic region, the syrinx may not regress after the first surgery and potentially predicting the need for a second operation before PFD.ConclusionsSSS placement for persistent syrinx following PFD for CM1 is a safe and effective surgical treatment method. These criteria may also help predict the need for a second surgery and the overall disease outcome for both the surgeon and patient.Copyright © 2023 Elsevier Inc. All rights reserved.

23 keywords...

hide…